F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Bevacizumab

Page 1 of 1 ( 38 items )
<<
1
>>

1	Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment 10/25/2024 10:27:31 AM \| Browse: 91 \| Download: 424
2	Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1 8/8/2024 4:58:16 AM \| Browse: 162 \| Download: 591
3	Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients 11/15/2022 10:19:35 AM \| Browse: 556 \| Download: 1935
4	Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review 7/14/2022 8:05:03 AM \| Browse: 618 \| Download: 1799
5	Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report 6/24/2022 9:00:24 AM \| Browse: 495 \| Download: 1389
6	Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice 9/22/2021 8:09:41 AM \| Browse: 622 \| Download: 975
7	Colorectal cancer metastatic to the breast: A case report 9/10/2020 5:57:28 AM \| Browse: 881 \| Download: 1661
8	Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report 7/20/2020 2:28:50 AM \| Browse: 882 \| Download: 2114
9	Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports 4/28/2020 8:04:31 AM \| Browse: 958 \| Download: 1684
10	Primary tumor location and survival in colorectal cancer: A retrospective cohort study 4/15/2020 12:00:00 PM \| Browse: 896 \| Download: 1861
11	Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy 2/22/2019 4:33:37 AM \| Browse: 1147 \| Download: 1371
12	Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review 1/16/2019 8:39:45 AM \| Browse: 952 \| Download: 1923
13	Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors 12/14/2018 10:51:23 AM \| Browse: 969 \| Download: 1377
14	CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer 11/13/2018 8:04:45 AM \| Browse: 1193 \| Download: 1911
15	Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia 12/20/2016 1:38:00 PM \| Browse: 1315 \| Download: 2277
16	Role of targeted therapy in metastatic colorectal cancer 9/12/2016 10:43:00 AM \| Browse: 1213 \| Download: 2075
17	Treatment of diabetic retinopathy: Recent advances and unresolved challenges 8/23/2016 8:55:00 AM \| Browse: 1237 \| Download: 2063
18	Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer 7/15/2016 3:38:00 PM \| Browse: 1384 \| Download: 2257
19	Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment 9/30/2015 4:28:00 PM \| Browse: 1448 \| Download: 2034
20	Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 6/20/2015 5:38:00 PM \| Browse: 1622 \| Download: 3163
21	Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab 5/13/2015 10:38:00 AM \| Browse: 1262 \| Download: 2665
22	Value of bevacizumab in treatment of colorectal cancer: A meta-analysis 4/27/2015 4:29:00 PM \| Browse: 1341 \| Download: 2016
23	Targeted therapy in first line treatment of RAS wild type colorectal cancer 3/16/2015 6:04:00 PM \| Browse: 1248 \| Download: 1705
24	FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma 2/11/2015 4:38:00 PM \| Browse: 1171 \| Download: 1340
25	Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status 11/19/2014 2:49:00 PM \| Browse: 1263 \| Download: 1592
26	Bevacizumab maintenance in metastatic colorectal cancer: How long? 11/10/2014 12:19:00 PM \| Browse: 1209 \| Download: 1750
27	Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy 10/20/2014 9:54:00 AM \| Browse: 1268 \| Download: 1915
28	Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases 9/16/2014 6:10:00 PM \| Browse: 1317 \| Download: 1270
29	Role of bevacizumab in colorectal cancer growth and its adverse effects: A review 9/15/2014 8:54:00 PM \| Browse: 1363 \| Download: 1412
30	Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives 9/11/2014 8:40:00 PM \| Browse: 1185 \| Download: 1711
31	Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012 9/3/2014 11:44:00 AM \| Browse: 1279 \| Download: 1714
32	Bevacizumab for the management of diabetic macular edema 9/1/2014 3:42:00 PM \| Browse: 1307 \| Download: 1256
33	Ranibizumab in diabetic macular edema 9/1/2014 2:50:00 PM \| Browse: 1277 \| Download: 1433
34	Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer 9/1/2014 10:30:00 AM \| Browse: 1456 \| Download: 1140
35	Targeting receptor tyrosine kinases in gastric cancer 8/28/2014 5:50:00 PM \| Browse: 1275 \| Download: 1493
36	Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review 8/26/2014 5:16:00 PM \| Browse: 1336 \| Download: 1137
37	Advances and new perspectives in the treatment of metastatic colon cancer 8/26/2014 4:37:00 PM \| Browse: 1374 \| Download: 1682
38	Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer 8/26/2014 4:36:00 PM \| Browse: 1357 \| Download: 1273

Page 1 of 1 ( 38 items )
<<
1
>>

1	Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment 10/25/2024 10:27:31 AM \| Browse: 91 \| Download: 424
2	Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1 8/8/2024 4:58:16 AM \| Browse: 162 \| Download: 591
3	Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients 11/15/2022 10:19:35 AM \| Browse: 556 \| Download: 1935
4	Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review 7/14/2022 8:05:03 AM \| Browse: 618 \| Download: 1799
5	Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report 6/24/2022 9:00:24 AM \| Browse: 495 \| Download: 1389
6	Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice 9/22/2021 8:09:41 AM \| Browse: 622 \| Download: 975
7	Colorectal cancer metastatic to the breast: A case report 9/10/2020 5:57:28 AM \| Browse: 881 \| Download: 1661
8	Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report 7/20/2020 2:28:50 AM \| Browse: 882 \| Download: 2114
9	Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports 4/28/2020 8:04:31 AM \| Browse: 958 \| Download: 1684
10	Primary tumor location and survival in colorectal cancer: A retrospective cohort study 4/15/2020 12:00:00 PM \| Browse: 896 \| Download: 1861
11	Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy 2/22/2019 4:33:37 AM \| Browse: 1147 \| Download: 1371
12	Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review 1/16/2019 8:39:45 AM \| Browse: 952 \| Download: 1923
13	Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors 12/14/2018 10:51:23 AM \| Browse: 969 \| Download: 1377
14	CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer 11/13/2018 8:04:45 AM \| Browse: 1193 \| Download: 1911
15	Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia 12/20/2016 1:38:00 PM \| Browse: 1315 \| Download: 2277
16	Role of targeted therapy in metastatic colorectal cancer 9/12/2016 10:43:00 AM \| Browse: 1213 \| Download: 2075
17	Treatment of diabetic retinopathy: Recent advances and unresolved challenges 8/23/2016 8:55:00 AM \| Browse: 1237 \| Download: 2063
18	Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer 7/15/2016 3:38:00 PM \| Browse: 1384 \| Download: 2257
19	Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment 9/30/2015 4:28:00 PM \| Browse: 1448 \| Download: 2034
20	Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 6/20/2015 5:38:00 PM \| Browse: 1622 \| Download: 3163
21	Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab 5/13/2015 10:38:00 AM \| Browse: 1262 \| Download: 2665
22	Value of bevacizumab in treatment of colorectal cancer: A meta-analysis 4/27/2015 4:29:00 PM \| Browse: 1341 \| Download: 2016
23	Targeted therapy in first line treatment of RAS wild type colorectal cancer 3/16/2015 6:04:00 PM \| Browse: 1248 \| Download: 1705
24	FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma 2/11/2015 4:38:00 PM \| Browse: 1171 \| Download: 1340
25	Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status 11/19/2014 2:49:00 PM \| Browse: 1263 \| Download: 1592
26	Bevacizumab maintenance in metastatic colorectal cancer: How long? 11/10/2014 12:19:00 PM \| Browse: 1209 \| Download: 1750
27	Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy 10/20/2014 9:54:00 AM \| Browse: 1268 \| Download: 1915
28	Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases 9/16/2014 6:10:00 PM \| Browse: 1317 \| Download: 1270
29	Role of bevacizumab in colorectal cancer growth and its adverse effects: A review 9/15/2014 8:54:00 PM \| Browse: 1363 \| Download: 1412
30	Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives 9/11/2014 8:40:00 PM \| Browse: 1185 \| Download: 1711
31	Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012 9/3/2014 11:44:00 AM \| Browse: 1279 \| Download: 1714
32	Bevacizumab for the management of diabetic macular edema 9/1/2014 3:42:00 PM \| Browse: 1307 \| Download: 1256
33	Ranibizumab in diabetic macular edema 9/1/2014 2:50:00 PM \| Browse: 1277 \| Download: 1433
34	Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer 9/1/2014 10:30:00 AM \| Browse: 1456 \| Download: 1140
35	Targeting receptor tyrosine kinases in gastric cancer 8/28/2014 5:50:00 PM \| Browse: 1275 \| Download: 1493
36	Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review 8/26/2014 5:16:00 PM \| Browse: 1336 \| Download: 1137
37	Advances and new perspectives in the treatment of metastatic colon cancer 8/26/2014 4:37:00 PM \| Browse: 1374 \| Download: 1682
38	Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer 8/26/2014 4:36:00 PM \| Browse: 1357 \| Download: 1273